Correction: Scalable synthesis and structural characterization of reversible KLK6 inhibitors

RSC Adv. 2022 Oct 10;12(44):28677. doi: 10.1039/d2ra90102a. eCollection 2022 Oct 4.

Authors

Andreas Baumann¹, Daniel Isak¹, Jasmin Lohbeck¹, Pravin Kumar Ankush Jagtap², Janosch Hennig^{2

3}, Aubry K Miller^{1

4}

Affiliations

¹ Cancer Drug Development Group, German Cancer Research Center (DKFZ) Im Neuenheimer Feld 280 69120 Heidelberg Germany aubry.miller@dkfz.de.
² Structural and Computational Biology Unit, European Molecular Biology Laboratory (EMBL) 69117 Heidelberg Germany.
³ Chair of Biochemistry IV, Biophysical Chemistry, University of Bayreuth 95447 Bayreuth Germany.
⁴ German Cancer Consortium (DKTK) Im Neuenheimer Feld 280 69120 Heidelberg Germany.

Abstract

[This corrects the article DOI: 10.1039/D2RA04670A.].

This journal is © The Royal Society of Chemistry.

Publication types

Published Erratum